NCEH1 and breast carcinoma: KIAA1363 was originally characterized as a membrane-associated serine hydrolase highly upregulated in the invasive melanoma cell line MUM-2B, the breast carcinoma cell line MDA-MB-231, and in the ovarian carcinoma cell lines OVCAR-5 and SKOV-3 [22].